Robert G. Conway - 09 Nov 2022 Form 4 Insider Report for AGILE THERAPEUTICS INC

Role
Chief Supply Chain Officer
Signature
/s/ Geoffrey P. Gilmore, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
09 Nov 2022
Net transactions value
$0
Form type
4
Filing time
14 Nov 2022, 15:33:16 UTC
Previous filing
20 Jan 2022
Next filing
30 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +10,000 $0.000000 10,000 09 Nov 2022 Common Stock 10,000 $0.2000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on November 9, 2022. 25% of the shares subject to the stock option vest on November 9, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on November 9, 2026.